BioSpace News Archive

BIOXYTRAN, INC. announced that its preprint article titled “Evaluation of Complex Carbohydrates Showing Broad-Spectrum Antiviral Activity Against SARS-CoV-2, Influenzas-a, and Human Respiratory Syncytial Virus Strain A2 in ‘In Vitro’ Setting” contains data showing a significant reduction of viral load in COVID-19, influenza and in human Respiratory Syncytial Virus.

Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac ablation procedures.

Moderna, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for Spikevax, its updated COVID-19 vaccine containing spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older.

First Wave BioPharma, Inc. announced it has entered into agreements with certain holders of its existing warrants exercisable for 5,882,036 shares of its common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $0.43 per share, in exchange for new warrants as described below.

The American Urological Association released the 2023 clinical practice guideline amendment for the management of lower urinary tract symptoms attributed to benign prostatic hyperplasia.

Kewaunee Scientific Corporation announces the Company’s new LOOKBOOK, which will be rolled out globally during the 2023 Arablab Live tradeshow and conference being held in Dubai during September 19-21.

TRANSGENE, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that Management will participate in several investor events, as set out below.

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, presented 21 new scientific and clinical studies on the company’s Equinoxe® shoulder at the 2023 International Congress on Shoulder and Elbow Surgery (ICSES) annual meeting Sept. 5-8 in Rome.

Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced it has rescheduled the investor and analyst conference call previously scheduled for September 15 at 10 a.m. Eastern Time.

Treace Medical Concepts, Inc., a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus through its Lapiplasty® 3D Bunion Correction® Procedure, is pleased to announce the United States Patent and Trademark Office’s forthcoming issuance of U.S. Patent No. 11,771,467, to publish on October 3, 2023.